查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417401

全球下游製程市場：趨勢、預測與競爭分析（~2030 年）

Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球下游加工市場規模預計將達536億美元，2024年至2030年年複合成長率為13.2%。該市場的主要驅動力包括生物製藥領域研發支出的成長、對生物製藥的需求不斷成長、膜過濾的使用增加以及濃縮技術在疫苗和生物製藥生產中的重要性。全球下游加工市場前景廣闊，生物製藥製造商和受託製造廠商市場蘊藏機會。

下游加工市場洞察

Lucintel 預測，由於下游精製技術在製造一流產品方面取得了進步，疫苗製造在預測期內仍將是最大的細分市場。

在這個市場中，由於老齡化人口對生物製藥的需求不斷成長，生物製藥製造商將繼續成為最大的細分市場。

由於政府支持力度加大、研發基礎設施日趨成熟以及專業知識和學術成果水準不斷提高，亞太地區預計將在預測期內實現最高成長。

常問問題

Q1.市場規模有多大？

A1. 至2030年，全球下游加工市場預計將達到536億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球下游加工市場預計年複合成長率為13.2%。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是生物製藥領域研發支出的成長、對生物製藥的需求不斷成長、膜過濾的使用增加以及濃縮技術在疫苗和生物製藥生產中的重要性。

Q4.市場的主要細分市場是什麼？

A4. 下游加工市場前景廣闊，為生物製藥製造商和受託製造廠商市場帶來機會。

Q5.市場上主要企業有哪些？

A5.主要下游加工企業如下。

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於製造一流產品的下游精製技術的進步，疫苗製造在預測期內仍將是其最大的部分。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於政府支持力度加大、研發基礎設施日趨成熟以及專業知識和學術成果水平不斷提高，亞太地區預計將在預測期內實現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球下游加工市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球下游製程市場趨勢（2018-2023）與預測（2024-2030）
  • 全球下游加工市場：依技術分類
    • 精製
    • 固液分離
    • 澄清/濃縮
  • 全球下游加工市場：依產品分類
    • 層析管柱/樹脂
    • 篩選
    • 膜吸附劑
    • 一次性產品
    • 其他
  • 全球下游加工市場：依應用分類
    • 單株抗體生產
    • 疫苗生產
    • 胰島素產生
    • 免疫球蛋白生產
    • 促血紅細胞生長素的產生
    • 其他
  • 全球下游加工市場：依最終用途產業
    • 生物製藥製造商
    • 契約製造組織
    • 其他

第4章市場趨勢與預測分析：按地區（2018-2030）

  • 全球下游加工市場：按地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依技術
    • 依產品
    • 按用途
    • 按最終用途行業
    • 按地區
  • 全球下游加工市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球下游加工市場的產能
    • 全球下游加工市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions
簡介目錄

Downstream Processing Trends and Forecast

The future of the global downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets. The global downstream processing market is expected to reach an estimated $53.6 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Downstream Processing by Segment

The study includes a forecast for the global downstream processing by technique, product, application, end use industry, and region.

Downstream Processing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Purification
  • Solid-Liquid Separation
  • Clarification/Concentration

Downstream Processing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Chromatography Columns & Resins
  • Filters
  • Membrane Adsorbers
  • Single-Use Products
  • Others

Downstream Processing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibody Production
  • Vaccine Production
  • Insulin Production
  • Immunoglobulin Production
  • Erythropoietin Production
  • Others

Downstream Processing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations
  • Otherss

Downstream Processing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Downstream Processing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies downstream processing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the downstream processing companies profiled in this report include-

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Downstream Processing Market Insights

Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Within this market, biopharmaceutical manufacturers will remain the largest segment due to rising need for biopharmaceuticals among the elderly demographic.

APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Features of the Global Downstream Processing Market

Market Size Estimates: Downstream processing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Downstream processing market size by various segments, such as by technique, product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Downstream processing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technique, product, application, end use industry, and regions for the downstream processing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the downstream processing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the downstream processing market size?

Answer: The global downstream processing market is expected to reach an estimated $53.6 billion by 2030.

Q2. What is the growth forecast for downstream processing market?

Answer: The global downstream processing market is expected to grow with a CAGR of 13.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the downstream processing market?

Answer: The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

Q4. What are the major segments for downstream processing market?

Answer: The future of the downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets.

Q5. Who are the key downstream processing market companies?

Answer: Some of the key downstream processing companies are as follows.

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Q6. Which downstream processing market segment will be the largest in future?

Answer: Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Q7. In downstream processing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the downstream processing market by technique (purification, solid-liquid separation, and clarification/concentration), product (chromatography columns & resins, filters, membrane adsorbers, single-use products, and others), application (monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others), end use industry (biopharmaceutical manufacturers, contract manufacturing organizations, and otherss), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Downstream Processing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Downstream Processing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Downstream Processing Market by Technique
    • 3.3.1: Purification
    • 3.3.2: Solid-Liquid Separation
    • 3.3.3: Clarification/Concentration
  • 3.4: Global Downstream Processing Market by Product
    • 3.4.1: Chromatography Columns & Resins
    • 3.4.2: Filters
    • 3.4.3: Membrane Adsorbers
    • 3.4.4: Single-Use Products
    • 3.4.5: Others
  • 3.5: Global Downstream Processing Market by Application
    • 3.5.1: Monoclonal Antibody Production
    • 3.5.2: Vaccine Production
    • 3.5.3: Insulin Production
    • 3.5.4: Immunoglobulin Production
    • 3.5.5: Erythropoietin Production
    • 3.5.6: Others
  • 3.6: Global Downstream Processing Market by End Use Industry
    • 3.6.1: Biopharmaceutical Manufacturers
    • 3.6.2: Contract Manufacturing Organizations
    • 3.6.3: Otherss

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Downstream Processing Market by Region
  • 4.2: North American Downstream Processing Market
    • 4.2.2: North American Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.3: European Downstream Processing Market
    • 4.3.1: European Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.3.2: European Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.4: APAC Downstream Processing Market
    • 4.4.1: APAC Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.4.2: APAC Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.5: ROW Downstream Processing Market
    • 4.5.1: ROW Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.5.2: ROW Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Downstream Processing Market by Technique
    • 6.1.2: Growth Opportunities for the Global Downstream Processing Market by Product
    • 6.1.3: Growth Opportunities for the Global Downstream Processing Market by Application
    • 6.1.4: Growth Opportunities for the Global Downstream Processing Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Downstream Processing Market by Region
  • 6.2: Emerging Trends in the Global Downstream Processing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Downstream Processing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Downstream Processing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: GE Healthcare
  • 7.3: Sartorius Stedim Biotech
  • 7.4: Merck Millipore
  • 7.5: Danaher
  • 7.6: 3M
  • 7.7: Boehringer Ingelheim
  • 7.8: Lonza
  • 7.9: Eppendorf
  • 7.10: Finesse Solutions